Roche at the 2018 ASH's 60th Annual Meeting
Roche has hosted a live audio webcast and conference call on Tuesday, 4 December 2018.
| Agenda: | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations, Roche |
| Roche Hematology Strategy and Key data in CLL and AML | Sandra Horning, M.D., Chief Medical Officer and Head of Global Product Development |
| Key Data in NHL Nancy Valente, M.D., Vice President, Global Head of Hematology Development | Nancy Valente, M.D., Vice President, Global Head of Hematology Development |
| Key Data in Hemophilia A Gallia Levy, M.D., Group Medical Director, Hemlibra Global Development Leader | Gallia Levy, M.D., Group Medical Director, Hemlibra Global Development Leader |